Association between Swallowing Outcomes and Dose to Critical Swallow Structures in Patients Undergoing Transoral Robotic Surgery and Post-Operative Radiation Therapy

Nichols AC, Theurer J, Prisman E, Read N, Berthele E, Tran E et al. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. JCO 2022.

Swisher-McClure S, Lukens JN, Aggarwal C, Ahn P, Basu D, Bauml JM, Brody R, Chalian A, Cohen RB, Fotouhi-Ghiam A, Geiger G, Gershowitz J, Livolsi V, Mitra N, Montone K, Newman J, Ojerholm E, O’Malley B Jr, Rajasekaran K, Tan E, Weinstein G, Lin A. A phase 2 trial of alternative volumes of Oropharyngeal Irradiation for de-intensification (AVOID): omission of the Resected Primary Tumor Bed after Transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the Oropharynx. Int J Radiat Oncol Biol Phys. 2020;106(4):725–32. https://doi.org/10.1016/j.ijrobp.2019.11.021.

Article  PubMed  Google Scholar 

Fradet L, Charters E, Gao K, Froggatt C, Palme C, Riffat F, Nguyen K, Wu R, Milross C, Clark JR. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study. ANZ J Surg. 2022;92(3):511–7.

Article  PubMed  Google Scholar 

Dowthwaite S, Panizza B, O’Neill J, Porceddu S, Jackson JE, Chua B. Outcomes of primary trans-oral surgical management of early tonsillar squamous cell carcinoma with risk-adapted adjuvant radiotherapy. Australian J Otolaryngolgy 2019; 2.

Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O’Malley BW Jr, Ozer E, Thomas GR, Koch WM, Gross ND, Bell RB, Saba NF, Lango M, Méndez E, Burtness B. Phase II randomized trial of Transoral surgery and low-dose intensity modulated Radiation Therapy in Resectable p16 + locally Advanced Oropharynx Cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol. 2022;40(2):138–49. https://doi.org/10.1200/JCO.21.01752.

Article  CAS  PubMed  Google Scholar 

Genden EM, Kotz T, Tong CC, et al. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope. 2011;121(8):1668–74.

Article  PubMed  Google Scholar 

Patel SA, Magnuson JS, Holsinger FC, et al. Robotic surgery for primary head and neck squamous cell carcinoma of unknown site. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1203–11.

Article  PubMed  Google Scholar 

Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, et al. Assessment of toxic effects and Survival in Treatment Deescalation with Radiotherapy vs Transoral surgery for HPV-Associated Oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 Randomized Clinical Trial. JAMA Oncol. 2022;8(6):1–7.

Article  PubMed  PubMed Central  Google Scholar 

Hutcheson KA, Warneke CL, Yao CMKL, Zaveri J, Elgohari BE, Goepfert R, MD Anderson Head and Neck Cancer Symptom Working Group, et al. Dysphagia after primary Transoral robotic surgery with Neck Dissection vs nonsurgical therapy in patients with low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(11):1053–63.

Article  PubMed  PubMed Central  Google Scholar 

Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, Boon C, Cook A, De Winton E, Emson M, Foran B, Frogley R, Petkar I, Pettit L, Rooney K, Roques T, Srinivasan D, Tyler J, Hall E, DARS Trialist Group. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol. 2023;24(8):868–80. https://doi.org/10.1016/S1470-2045(23)00265-6.

Article  PubMed  Google Scholar 

Charters E, Wu R, Milross C, Bogaardt H, Freeman-Sanderson A, Ballard K, Davies S, Oates J, Clark J. Swallowing and communication outcomes following primary transoral robotic surgery. Head Neck. 2021;43(7):2013–23.

Article  PubMed  Google Scholar 

Charters E, Bogaardt H, Freeman-Sanderson A, Ballard K, Davies S, Oates J, Clark J. Swallowing and communication outcomes following primary transoral robotic surgery for advanced or recurrent oropharyngeal cancer: Case series. Int J Speech Lang Pathol. 2022;24(4):407–16.

Article  PubMed  Google Scholar 

Bhide SA, Gulliford S, Kazi R, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol. 2009;93(3):539–44.

Article  PubMed  Google Scholar 

Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(4):1110–8.

Article  PubMed  Google Scholar 

Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2010;76(2):403–9.

Article  PubMed  Google Scholar 

Dirix P, Abbeel S, Vanstraelen B, Hermans R, Nuyts S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75(2):385–92.

Article  CAS  PubMed  Google Scholar 

Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet-and speech-related quality of life. Int J Radiat Oncol Biol Phys. 2007;68(3):750–7.

Article  PubMed  Google Scholar 

Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289–98.

Article  PubMed  Google Scholar 

Levendag PC, Teguh D, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose–effect relationship. Radiother Oncol. 2007;85:64–73.

Article  PubMed  Google Scholar 

Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity- modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(5):1356–65.

Article  PubMed  PubMed Central  Google Scholar 

Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101(3):394–402.

Article  PubMed  Google Scholar 

Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the MD Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870–6.

CAS  PubMed  Google Scholar 

Hutcheson KA, Bhayani MK, Beadle BM, et al. Eat and Exercise during Radiotherapy or Chemoradiotherapy for pharyngeal cancers: use it or lose it. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1127–34.

Article  PubMed  PubMed Central  Google Scholar 

Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and as- piration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60:1425–39.

Article  PubMed  Google Scholar 

Eisbruch A, Kim HM, Feng FY, Lyden TH, Haxer MJ, Feng M, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiation Oncol Biol Phys. 2011;81(3):e93–9.

Article  Google Scholar 

Awan M, Mohamed ASR, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, et al. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014;50:746–52.

Article  PubMed  PubMed Central  Google Scholar 

Dabas S, Gupta K, Ranjan R, Sharma AK, Shukla H, Dinesh A. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): a prospective trial. Oral Oncol. 2017;69:80–3. Epub 2017 Apr 21. PMID: 28559025.

Article  PubMed  Google Scholar 

Weinstein GS, Quon G, O’Malley BW, Kim GG, Cphen MA. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the university of Pennsylvania transoral robotic surgery trial. Laryngoscope. 2010;120(9):1749–55.

Article  PubMed  Google Scholar 

Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? Laryngoscope. 2016;126(5):1108–13.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif